EA201101036A1 - Применение хлорида аммония в терапии - Google Patents

Применение хлорида аммония в терапии

Info

Publication number
EA201101036A1
EA201101036A1 EA201101036A EA201101036A EA201101036A1 EA 201101036 A1 EA201101036 A1 EA 201101036A1 EA 201101036 A EA201101036 A EA 201101036A EA 201101036 A EA201101036 A EA 201101036A EA 201101036 A1 EA201101036 A1 EA 201101036A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treating
liver
interferons
therapy
application
Prior art date
Application number
EA201101036A
Other languages
English (en)
Other versions
EA024723B1 (ru
Inventor
Диамантис Киассос
Алессандро Ганьони
Original Assignee
Рейнбоу Фармасьютикал С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рейнбоу Фармасьютикал С.А. filed Critical Рейнбоу Фармасьютикал С.А.
Publication of EA201101036A1 publication Critical patent/EA201101036A1/ru
Publication of EA024723B1 publication Critical patent/EA024723B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение имеет отношение к способу лечения печёночной недостаточности и некроза печени, вызванными различными токсическими веществами, и лечения вирусных инфекций или других болезней, в частности опухолей, которые можно лечить с помощью интерферонов. Конкретнее, настоящее изобретение имеет отношение к способу лечения или предотвращения вирусной инфекции, печеночной недостаточности, некроза печени или других состояний, вызванных токсическими веществами, или аутоиммунной реакцией, или опухолью, которая является чувствительной к лечению интерферонами α, β или γ, указанный способ включает введение фармацевтически эффективного количества лекарственной формы NHCl вместе с фармацевтически приемлемыми эксципиентами пациенту, нуждающемуся в этом.
EA201101036A 2009-01-02 2009-12-29 Применение лекарственной формы хлорида аммония для профилактики или лечения вирусной инфекции и состояний, вызванных токсическими веществами EA024723B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/348,220 US8840934B2 (en) 2009-01-02 2009-01-02 Uses of ammonium chloride
PCT/EP2009/067993 WO2010076323A1 (en) 2009-01-02 2009-12-29 Use of ammonium chloride in therapy

Publications (2)

Publication Number Publication Date
EA201101036A1 true EA201101036A1 (ru) 2012-01-30
EA024723B1 EA024723B1 (ru) 2016-10-31

Family

ID=41649998

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201101036A EA024723B1 (ru) 2009-01-02 2009-12-29 Применение лекарственной формы хлорида аммония для профилактики или лечения вирусной инфекции и состояний, вызванных токсическими веществами

Country Status (15)

Country Link
US (1) US8840934B2 (ru)
EP (1) EP2373320A1 (ru)
JP (1) JP2012514583A (ru)
KR (1) KR20110101125A (ru)
CN (1) CN102209549A (ru)
AP (1) AP3436A (ru)
AU (1) AU2009334784B2 (ru)
BR (1) BRPI0923886A2 (ru)
CA (1) CA2740521A1 (ru)
EA (1) EA024723B1 (ru)
IL (1) IL212208A0 (ru)
MX (1) MX2011004189A (ru)
NZ (1) NZ592077A (ru)
WO (1) WO2010076323A1 (ru)
ZA (1) ZA201102416B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
UY34402A (es) 2011-10-21 2013-05-31 Abbvie Inc Métodos para el tratamiento de hcv
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
CN104023726A (zh) 2011-10-21 2014-09-03 艾伯维公司 用于治疗hcv的一种或多种daa的联合治疗(例如，与abt-072或abt-333)
US11192914B2 (en) 2016-04-28 2021-12-07 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540979A (en) * 1948-04-24 1951-02-06 Smith Kline French Lab Enteric coating
US4346082A (en) * 1980-01-04 1982-08-24 The Vinoxen Company Method of employing therapeutic composition comprising ammonium or substituted ammonium compounds for treatment of alcoholism
EP0095833A3 (en) * 1982-05-03 1984-12-27 Roland Vilagines Method of preventing infection by viropexis-penetrating viruses
NL8401782A (nl) 1984-06-04 1986-01-02 Jan Willem Bins Therapeutisch preparaat met ammoniumnitraat als werkzame stof.
NZ231236A (en) 1988-11-11 1992-07-28 Manrex Australia Pty Ltd Assembly for blister package
US5275828A (en) * 1989-11-08 1994-01-04 Hooper Oswald E Treatment and/or a method of treating equine viral and bacterial infections
AU642173B2 (en) * 1989-11-08 1993-10-14 Oswald Edmonds Hooper Improvements in or relating to a treatment and or a method of treating
JPH0789862A (ja) * 1990-05-29 1995-04-04 Toyobo Co Ltd 抗炎症性、免疫抑制性および鎮痛性組成物、およびこれらの組成物を用いた自己免疫疾患の治療方法
WO1996032952A1 (en) 1995-04-21 1996-10-24 Oswald Edmonds Hooper Caffeine composition as medicament and use thereof
SE9200502D0 (sv) 1992-02-20 1992-02-20 Astra Ab Novel antioxidants
MX9503783A (es) 1995-09-04 1997-03-29 William C Stacey Combinaciones de compuestos de cloruro de amonio para el tratamiento de infecciones virales.
SI9700186B (sl) 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
ES2137862B1 (es) * 1997-07-31 2000-09-16 Intexim S A Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
GR1003980B (el) 2001-04-20 2002-09-03 Ιωαννου Διαμαντης Κιασσος Νεα χρηση του χλωριουχου αμμωνιου για τη θεραπεια των ενδοηπατικων χολοστασεων οφειλομενων εις δυσπραγια του ηπατικου κυτταρου
US20030162732A1 (en) * 2001-07-05 2003-08-28 Astion Development A/S Combination of aminosugars and cysteine or cysteine derivatives
GR20020100405A (el) 2002-09-12 2004-05-24 Διαμαντης Ιωαννου Κιασσος Νεα χρηση του nh4 cl για την θεραπεια της ηπατικης ινωσεως νεκρωσεως και εγκεφαλοπαθιας οξειας και χρονιας ηπατικης ανεπαρκειας. νεα χρηση του nh4 cl για την θεραπεια της υπερχολερυθριναιμιας, υπερτρασανεμιας προκιρρωτικων και κιρρωτικων καταστασεων του ηπατος, ως επισης για την προληψη της μετατροπης των ως ανω νοσηματων εις νεοπλασματα του ηπατος.
CA2617941C (en) 2004-08-23 2012-07-24 Pejo Iserlohn Heilmittel Und Diaet Gmbh & Co. Kg Psychostimulant containing pharmaceutical composition
EP1906934A4 (en) 2005-07-14 2012-03-07 Franco Folli DAILY DOSAGE SCHEME FOR THE TREATMENT OF DIABETES, OBESITY, METABOLIC SYNDROME AND POLYKYSTIC OVAIRE SYNDROME
AR055106A1 (es) * 2005-08-05 2007-08-08 Osmotica Pharmaceutical Argent Composicion farmaceutica solida de liberacion extendida que contiene carbidopa y levodopa
US20070251852A1 (en) * 2006-04-28 2007-11-01 David Purdy Multiple medication package
PT1875918E (pt) 2006-07-03 2013-12-26 Rainbow Pharmaceutical Sa Nova utilização de cloreto de amónio para a terapia de insuficiência e necrose hepática total ou parcial

Also Published As

Publication number Publication date
AU2009334784A1 (en) 2010-07-08
EA024723B1 (ru) 2016-10-31
JP2012514583A (ja) 2012-06-28
MX2011004189A (es) 2011-08-12
AP2011005798A0 (en) 2011-08-31
AU2009334784B2 (en) 2014-01-16
NZ592077A (en) 2013-05-31
WO2010076323A1 (en) 2010-07-08
CA2740521A1 (en) 2010-07-08
IL212208A0 (en) 2011-06-30
CN102209549A (zh) 2011-10-05
ZA201102416B (en) 2012-06-27
AP3436A (en) 2015-10-31
US8840934B2 (en) 2014-09-23
BRPI0923886A2 (pt) 2015-07-28
US20100173020A1 (en) 2010-07-08
EP2373320A1 (en) 2011-10-12
KR20110101125A (ko) 2011-09-15

Similar Documents

Publication Publication Date Title
EA201201235A1 (ru) Комбинации фармацевтических агентов в качестве ингибиторов репликации hcv
TW200733953A (en) Materials and methods for treating viral infections
EA201270144A1 (ru) Комбинированная терапия при лечении диабета
EA201650134A1 (ru) Специфическая сочетанная терапия злокачественных опухолей цитостатиком и его модификатором
EA201490254A1 (ru) Комбинированное лечение гепатита с
EA202092343A1 (ru) Лечение гнойного гидраденита с использованием ингибиторов jak
EA200971053A1 (ru) Способы лечения кожных язв
EA200802412A1 (ru) Терапевтические комбинации для сопровождающихся болью медицинских состояний
EA201491081A1 (ru) Композиции и способы для лечения заболеваний и расстройств печени
EA201170484A1 (ru) Терапевтический режим лечения гепатита, включающий пэг-интерферон, рибавирин и vx-950
EA201300421A1 (ru) Комбинированная терапия для лечения инфекции hcv
RU2015114543A (ru) Способы лечения гепатита с
MX2012008652A (es) Terapias para tratar infeccion por virus de hepatitis c.
EA201101036A1 (ru) Применение хлорида аммония в терапии
BR112012030641A2 (pt) métodos e composições para terapia farmacêutica oral
MX2022006742A (es) Uso y composicion farmaceutica de derivados de fenilisoxazolil metilen-naftaleno-eter.
PH12021550632A1 (en) Monomer and multimeric anti-hbv agents
BR112012020185A2 (pt) uso de preparações de heparina oral para tratar doenças e afecções do trato urinário.
PH12015502128A1 (en) Novel dosing regimens of celgosivir for the treatment of dengue
EA201790352A1 (ru) Терапевтическое лечение на основе анаморелина
WO2016090107A3 (en) Treatment of hepatitis delta virus infection
NO20064754L (no) Kombinasjonsterapi
JP2019529569A5 (ru)
RU2015114566A (ru) Способы лечения гепатита с
RU2013120345A (ru) Новые способы лечения инфекции, вызванной вирусом гепатита с

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment